Literature DB >> 20818996

Liquid nitrogen cryotherapy on Leishmania donovani cutaneous leishmaniasis.

Ranthilaka R Ranawaka1, Hema S Weerakoon, Nandimithra Opathella.   

Abstract

OBJECTIVE: To evaluate the efficacy and the safety of liquid nitrogen cryotherapy (LN) on Leishmania donovani cutaneous leishmaniasis and on type V skin.
METHODS: LN was applied to 65 patients (121 lesions) using cotton swabs attached to ekels. Cryosessions were performed for 15-20 seconds, two per site, weekly for 1-3 weeks, fortnightly for 4-5 weeks and then monthly until cure. Patients were followed-up for 6 months after cure.
RESULTS: A total of 91.7% of patients were cured within one to seven cryosessions; mean 3.57. With one to four cryosessions, papules ≤ 1 cm in diameter showed rapid healing (90.5%) in comparison with those of > 1 cm diameter (64.28%). The cure rates for lesions on the head (84.61%) and upper limb (82.6%) were greater than those for the lower limbs (71.42%) and trunk (66.66%). With LN, local pain lasted for 15-30 minutes; ulceration (33%), depigmentation (46.9%) and scarring (43%) were noticed. During 6 months of follow-up there was one (1.6%) recurrence.
CONCLUSIONS: LN (77.15% cure within one to four cryosessions) is an alternative to intralesional sodium stibogluconate in the treatment of papules measuring ≤ 1 cm. In type V skin, LN should be avoided on the face, and on patients who have a tendency to form keloids. We recommend giving cryotherapy using cryoguns (instead of cotton swabs attached to ekels) fortnightly (not weekly), which may minimize ulceration, and therefore scarring.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20818996     DOI: 10.3109/09546631003762654

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  7 in total

Review 1.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 2.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-11-17

Review 3.  An update on pharmacotherapy for leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Pharmacother       Date:  2014-10-25       Impact factor: 3.889

4.  Use of a clinical tool for screening and diagnosis of cutaneous leishmaniasis in Sri Lanka.

Authors:  H V Y D Siriwardana; U Senarath; P H Chandrawansa; N D Karunaweera
Journal:  Pathog Glob Health       Date:  2015-07-16       Impact factor: 2.894

Review 5.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-12-01

6.  Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination.

Authors:  Hermali Silva; Achala Liyanage; Theja Deerasinghe; Vasana Chandrasekara; Kalaivani Chellappan; Nadira D Karunaweera
Journal:  PLoS One       Date:  2021-10-22       Impact factor: 3.240

Review 7.  A Comprehensive Review of Cutaneous Leishmaniasis in Sri Lanka and Identification of Existing Knowledge Gaps.

Authors:  Anjalie Amarasinghe; Susiji Wickramasinghe
Journal:  Acta Parasitol       Date:  2020-02-12       Impact factor: 1.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.